Experimental Alzheimer's drug from Roche fails in trials - The Washington Post

Retrieved on: 2022-11-14 22:05:21

Tags for this article:

Click the tags to see associated articles and topics

Experimental Alzheimer's drug from Roche fails in trials - The Washington Post. View article details on hiswai:

Excerpt

Genentech, a division of health-care giant Roche, said in a news release Monday that the treatment, called gantenerumab, slowed the pace of ...

Article found on: www.washingtonpost.com